Indeed, UCP2 overexpression protects against ROS production and increases the apoptotic threshold for cancer cell survival (Zhang et al. 2007), while UCP2 knockdown or pharmacological inhibition leads to an increase in mitochondrial ROS, as observed in UCP2 knockout mice (Arsenijevic et al. 2000). This evidence concerns the gene UCP2 and cancer.